BG25654A3 - METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES - Google Patents

METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES

Info

Publication number
BG25654A3
BG25654A3 BG019320A BG1932071A BG25654A3 BG 25654 A3 BG25654 A3 BG 25654A3 BG 019320 A BG019320 A BG 019320A BG 1932071 A BG1932071 A BG 1932071A BG 25654 A3 BG25654 A3 BG 25654A3
Authority
BG
Bulgaria
Prior art keywords
actinomycetes
glycoside hydrolases
obtaining inhibitors
inhibitors
obtaining
Prior art date
Application number
BG019320A
Other languages
Bulgarian (bg)
Inventor
Werner Frommer
Walter Puls
Dietmar Schafer
Delf Schmidt
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG25654A3 publication Critical patent/BG25654A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
BG019320A 1970-12-28 1971-12-24 METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES BG25654A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (en) 1970-12-28 1970-12-28 Actinomycete glycoside hydrolase inhibitors

Publications (1)

Publication Number Publication Date
BG25654A3 true BG25654A3 (en) 1978-11-10

Family

ID=5792372

Family Applications (3)

Application Number Title Priority Date Filing Date
BG019320A BG25654A3 (en) 1970-12-28 1971-12-24 METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES
BG025075A BG26003A4 (en) 1970-12-28 1973-11-26 METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES
BG025074A BG26002A4 (en) 1970-12-28 1973-11-26 METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG025075A BG26003A4 (en) 1970-12-28 1973-11-26 METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES
BG025074A BG26002A4 (en) 1970-12-28 1973-11-26 METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES

Country Status (28)

Country Link
US (1) US3876766A (en)
JP (3) JPS5734996B1 (en)
KR (1) KR780000248B1 (en)
AR (1) AR193370A1 (en)
AT (1) AT330122B (en)
AU (1) AU461521B2 (en)
BE (1) BE777387A (en)
BG (3) BG25654A3 (en)
CA (1) CA979833A (en)
CH (1) CH594051A5 (en)
CS (1) CS167961B2 (en)
DD (1) DD99395A5 (en)
DE (1) DE2064092C2 (en)
DK (1) DK139533C (en)
ES (1) ES398358A1 (en)
FI (1) FI49774C (en)
FR (1) FR2120073B1 (en)
GB (1) GB1374751A (en)
IE (1) IE35920B1 (en)
IL (1) IL38441A (en)
LU (1) LU64319A1 (en)
NL (1) NL175199C (en)
NO (1) NO135873C (en)
PL (1) PL82900B1 (en)
RO (3) RO61400A (en)
SE (1) SE398357B (en)
SU (1) SU454750A3 (en)
ZA (1) ZA718677B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209833C3 (en) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Manufacture of an amylase inhibitor
DE2209834C3 (en) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Manufacture of saccharase inhibitors
DE2209832C3 (en) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Manufacture of saccharase inhibitors
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (en) * 1976-01-22 1977-08-19 Rhone Poulenc Ind NEW GLYCO-HYDROLASE INHIBITOR AND ITS PREPARATION BY CULTURE OF A STREPTOMYCES
DE2658563A1 (en) * 1976-12-23 1978-06-29 Bayer Ag Glucoside hydrolase inhibitors prodn. from bacteria - esp. Bacillus species useful, e.g., for increasing meat yields and feed efficiency
DE2701890C2 (en) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Streptomycete peptic glycoside hydrolase inhibitor and its use
DE2719912C3 (en) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Process for the isolation of 0- | 4,6-dideoxy-4- [JJl SO, 4,6 / 5) -4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a - D-glucopyranosyl} - (I right arrow 4) -0- a D-glucopyranosyl- (l right arrow 4) -D-glucopyranose from culture broths
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (en) * 1986-01-07 1987-07-16 シャープ株式会社 Electronic automatic flicker
ATE89563T1 (en) * 1986-08-13 1993-06-15 Hoechst Ag OXIRAN-PSEUDOOLIGOSACCHARIDES, PROCESSES FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL PREPARATIONS.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (en) * 1995-03-02 1996-10-31 Bayer Ag Acarbose biosynthesis genes from Actinoplanes sp., Process for their isolation and their use
EP0796915A3 (en) * 1996-03-22 1999-04-14 Bayer Ag Process for the preparation and use of acarviosyl-transferase in the conversion of ascarbose-homologous in acarbose and in the preparation of acarbose-homologous
DE19637591A1 (en) * 1996-09-13 1998-03-19 Bayer Ag Osmocontrolled fermentation process for the production of acarbose
DE10085149B4 (en) 1999-10-28 2008-06-19 Chong Kun Dang Pharmaceutical Corp. Process for the production of acarbose with a high degree of purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
KR20140109922A (en) 2011-12-08 2014-09-16 바이엘 인텔렉쳐 프로퍼티 게엠베하 New actinomycete integrative and conjugative element from actinoplanes sp. se50/110 as plasmid for genetic transformation of related actinobacteria
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
EP4045520A1 (en) 2019-10-16 2022-08-24 Bayer Aktiengesellschaft Methods for the improved formation of acarbose
WO2021195087A1 (en) 2020-03-23 2021-09-30 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
AR193370A1 (en) 1973-04-23
JPS5734996B1 (en) 1982-07-26
RO61400A (en) 1977-01-15
DD99395A5 (en) 1973-08-05
JPS57150395A (en) 1982-09-17
LU64319A1 (en) 1972-06-13
ES398358A1 (en) 1974-09-01
FI49774C (en) 1975-10-10
NO135873C (en) 1977-06-15
AU461521B2 (en) 1975-05-29
BG26003A4 (en) 1979-01-12
DE2064092A1 (en) 1972-07-20
FR2120073A1 (en) 1972-08-11
US3876766A (en) 1975-04-08
SE398357B (en) 1977-12-19
DK139533B (en) 1979-03-05
RO63065A (en) 1979-02-15
DE2064092C2 (en) 1983-06-01
NL175199B (en) 1984-05-01
IE35920B1 (en) 1976-06-23
JPS57150396A (en) 1982-09-17
AT330122B (en) 1976-06-10
DK139533C (en) 1979-08-20
JPS6234396B2 (en) 1987-07-27
IE35920L (en) 1972-06-28
IL38441A0 (en) 1972-02-29
ATA1111571A (en) 1975-09-15
GB1374751A (en) 1974-11-20
BG26002A4 (en) 1979-01-12
ZA718677B (en) 1972-09-27
CA979833A (en) 1975-12-16
NL175199C (en) 1984-10-01
BE777387A (en) 1972-06-28
IL38441A (en) 1974-10-22
FR2120073B1 (en) 1975-12-26
NO135873B (en) 1977-03-07
NL7117893A (en) 1972-06-30
KR780000248B1 (en) 1978-07-06
CS167961B2 (en) 1976-05-28
PL82900B1 (en) 1975-10-31
FI49774B (en) 1975-06-30
AU3721471A (en) 1973-09-27
RO63064A (en) 1978-06-15
CH594051A5 (en) 1977-12-30
JPS6216638B2 (en) 1987-04-14
SU454750A3 (en) 1974-12-25

Similar Documents

Publication Publication Date Title
BG26003A4 (en) METHOD FOR OBTAINING INHIBITORS FOR GLYCOSIDE HYDROLASES FROM ACTINOMYCETES
BG20365A3 (en) METHOD FOR OBTAINING BENZYLPYRIMIDINE DERIVATIVES
BG21025A3 (en) METHOD FOR OBTAINING 2-PYRROLIDINONE DERIVATIVES
BG20100A3 (en) METHOD FOR OBTAINING 1-PHENOXY-2-HYDROXY-3- HYDROALKYL-AMINOPROPANES
BG21016A3 (en) METHOD FOR OBTAINING PHENYLAMINOALKANES
BG19373A3 (en) METHOD FOR OBTAINING THIOcarbamides
BG20610A3 (en) METHOD FOR OBTAINING TRIAZENES
SU430549A3 (en) METHOD FOR OBTAINING ACETYLATED GLYCOside DERIVATIVES
BG19138A3 (en) METHOD FOR OBTAINING PHENYLcarbamides
BG17788A3 (en) METHOD FOR OBTAINING PROPANE-3-OXA DERIVATIVES
BG18860A3 (en) METHOD FOR OBTAINING BENZAMIDE DERIVATIVES
BG18416A3 (en) METHOD FOR OBTAINING N-VINYLQUINOLONES
BG20555A3 (en) METHOD FOR OBTAINING N-ISOPROPYL-ANILINE
BG17979A3 (en) METHOD FOR OBTAINING DES-PHENYL-LANINE B1-INSULIN
BG17963A3 (en) METHOD FOR OBTAINING NEW CARDENALIDE-RHAMNOSIDES
BG19122A3 (en) METHOD FOR OBTAINING BORNAMINE DERIVATIVES
BG17574A3 (en) METHOD FOR OBTAINING ISOQUINOLINE DERIVATIVES
BG20355A3 (en) METHOD FOR OBTAINING TETRAHYDROISOQUINOLINE DERIVATIVES
BG21020A3 (en) METHOD FOR OBTAINING N-SUBSTITUTED ACETALDIMINES
BG20571A3 (en) METHOD FOR OBTAINING SULFANYLUREAS
BG17530A3 (en) METHOD FOR OBTAINING ALKYLAMINOPROPANES
BG17967A3 (en) METHOD FOR OBTAINING ISOQUINOLINE DERIVATIVES
BG18870A3 (en) METHOD FOR OBTAINING NEW 2-AMINO-DIHYDRO-BENZODIAZEPINONES
BG16584A3 (en) METHOD FOR OBTAINING NEW AMINOPROPIOPHENONES
BG17578A3 (en) METHOD FOR OBTAINING 5-NITRO-FURYL DERIVATIVES